Stockysis

Article

Leerink Partners Maintains Outperform on Elanco Animal Health, Raises Price Target to $30

Benzinga Newsdesk | Feb 24, 2026 20:16 | Source: www.benzinga.com

Leerink Partners analyst Daniel Clark maintains Elanco Animal Health (NYSE:ELAN) with a Outperform and raises the price target from $26 to $30.

Comments